Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05033639
Other study ID # ITRMC-REC-2021-008
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received
Last updated
Start date March 1, 2021
Est. completion date December 31, 2021

Study information

Verified date October 2023
Source Ilocos Training and Regional Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Prematurity is still one of the primary causes of death in children under 5. 1-2. According to the WHO, 60% of all preterm births occur in Asia, with the Philippines accounting for around 348,900 every year. 3. Necrotizing enterocolitis is one of the fatal complications (NEC) 3, 4. Preterm newborns weighing 1500 grams or less are considered high risk. 5-6. Melatonin is one chemical that may help prevent NEC. Melatonin is an endogenous indolamine derived from serotonin. It is a ubiquitous molecule that is crucial to the body's physiologic function. Melatonin, also known as N-acetyl-5-methoxytryptamine, is an immunomodulator, antioxidant, anti-inflammatory, and free radical scavenger7-10. It is a naturally occurring chemical that is simply replenished. With this in mind, the researcher wants to see if providing high dose melatonin to premature babies can prevent NEC.


Description:

Prematurity remains as one of the leading causes of mortality among children less than 5 years old1-2. The World Health Organization that 60 percent of all preterm births around the world occurs in Asian countries and roughly 348,900 births occur each year in the Philippines3. One complication that contribute to the high mortality is necrotizing enterocolitis (NEC)1, 3-4. High risk population include preterm infants weighing 1500 grams and lower with inverse correlation to the patient's weight5-6. One compound that could be used to prevent NEC is melatonin. Melatonin is an endogenously produced indolamine principally synthesized in the pineal gland from serotonin. It is described as a ubiquitous molecule which plays a vital role in the physiologic function of the body. Melatonin, also known as N-acetyl-5-methoxytryptamine which has a a) immunomodulator; b) free radical scavenger; c) prevention of oxidative stress and d) anti-inflammatory7-10. It is a naturally occurring substance and it would just be supplemented to increase its levels. With all this in mind, the researcher would like to determine if giving high dose melatonin among preterm neonates could prevent NEC among high risk population.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date December 31, 2021
Est. primary completion date December 31, 2021
Accepts healthy volunteers No
Gender All
Age group 28 Weeks to 36 Weeks
Eligibility Inclusion Criteria: - 1. Newborn with a pediatric age of less than 37 weeks categorized very preterm (28 to 32 weeks) and late preterm (32 to 36weeks) by the World Health Organization weighing not more than 1500. 2. Preterm infants admitted at the Neonatal Intensive care unit of Ilocos Training Regional and Medical Center not more than 24 hours of age. 3. Preterm infants with orogastric tube in place. 4. Preterm infants with no other condition other than prematurity and respiratory distress syndrome. 5. Preterm infant with an Apgar score of more than 6 in the first minute of life. Exclusion Criteria: 1. Preterm infants more than 1 day of life. 2. Preterm infants diagnosed with NEC 3. Preterm infants who is born to a mother of who considered as a minor (<18 years old) and is not married to the father of the unborn child. 4. Preterm infants that could not be fed through oral gastric tube due to a secondary problem. 5. Preterm infants with other comorbidities such as asphyxia, congenital anomalies, and other inherited disorders. 6. Meconium Stained Preterm infants -

Study Design


Intervention

Drug:
Melatonin 6 MG
Melatonin is an endogenously produced indolamine principally synthesized in the pineal gland from serotonin. It is described as a ubiquitous molecule which plays a vital role in the physiologic function of the body. Melatonin, also known as N-acetyl-5-methoxytryptamine which has a a) immunomodulator; b) free radical scavenger; c) prevention of oxidative stress and d) anti-inflammatory7-10.
Other:
Breast Milk
Naturally occurring milk from the mother of the infant.

Locations

Country Name City State
Philippines Ilocos Training and Regional Medical Center San Fernando LA Union

Sponsors (1)

Lead Sponsor Collaborator
Ilocos Training and Regional Medical Center

Country where clinical trial is conducted

Philippines, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number Of Preterm Infants Who Developed Necrotizing Enterocolits After Melatonin 6mg Tablet Prophylaxis effectiveness of melatonin in preventing NEC among preterm infants with a birthweight of 5 MONTHS
Secondary Incidence of Prematurity at Training and Regional Medical Center Clinical Profiles Of Preterm Infants Born In Ilocos Training and Regional Medical Center 5 MONTHS
Secondary Number of Patients Who Developed Abnormal Gas Pattern with Dilated Bowel Loops after Melatonin 6mg Tablet Prophylaxis Absence of Clinical And Radiologic Findings Diagnostic of Necrotizing Enterocolitis. 5 MONTHS
Secondary Number of Patients Who Developed Pneumatosis intestinalis after Melatonin 6mg Tablet Prophylaxis Absence of Clinical And Radiologic Findings Diagnostic of Necrotizing Enterocolitis. 5 Months
Secondary Number of Patients Who Developed Sentinel Loops after Melatonin 6mg Tablet Prophylaxis Absence of Clinical And Radiologic Findings Diagnostic of Necrotizing Enterocolitis. 5 Months
Secondary Number of Patients Who Developed Portal Venous Gas after Melatonin 6mg Tablet Prophylaxis Absence of Clinical And Radiologic Findings Diagnostic of Necrotizing Enterocolitis. 5 Months
Secondary Number Of Hospital Days Among Preterm Infants Admitted at Ilocos Training and Regional Medical Center Efficacy of Melatonin Oral Prophylaxis 5 Months
Secondary Number Of Days Before Oral FeedingAmong Preterm Infants Admitted at Ilocos Training and Regional Medical Center Efficacy of Melatonin Oral Prophylaxis 5 motnhs
See also
  Status Clinical Trial Phase
Recruiting NCT05544097 - Spectral Analysis of Bowel Sounds in Preterm Babies of Less Than 32 Weeks of Amenorrhea (WA) as Predictive Factor of Enterocolitis N/A
Recruiting NCT03210831 - Early Predictors of Necrotizing Enterocolitis in Neonates
Not yet recruiting NCT06045130 - PUFAs in Preterm Infants
Recruiting NCT02552706 - The Efficacy and Mechanisms of Oral Probiotics in Preventing Necrotizing Enterocolitis N/A
Completed NCT02400697 - Placental Transfusion Project for Preterm Infants N/A
Completed NCT01751477 - Infloran® for Prevention of Necrotizing Enterocolitis N/A
Terminated NCT01156480 - Anti-inflammatory Treatment at the Onset of Necrotizing Enterocolitis (NEC) in Preterm Infants N/A
Completed NCT00787124 - Transfusions and Nitric Oxide Level in Preterm Infants
Unknown status NCT00254176 - Cysteine Supplementation in Critically Ill Neonates Phase 2/Phase 3
Recruiting NCT01441739 - Intestinal Failure in Necrotising Enterocolitis N/A
Recruiting NCT03869827 - Necrotizing Enterocolitis in Fetuses With Intrauterine Growth Restriction
Recruiting NCT04074824 - A Genome-Wide Association Study for Neonatal Diseases
Terminated NCT03320785 - Circulating Markers in Preterm Infants With Perinatal and Neonatal Inflammation
Active, not recruiting NCT03554278 - Alteration of Stool Microbiota in Preterm Infants With Anemia
Not yet recruiting NCT04541771 - The Role of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis (NEC) in Pre-term Infants Phase 2
Not yet recruiting NCT03700957 - The Impact of Docosahexaenoic Acid on the Prevention of Necrotizing Enterocolitis in Preterm Neonates N/A
Completed NCT03551600 - Splanchnic and Renal Tissue Oxygenation During Enteral Feedings in Neonates With Patent Ductus Arteriosus
Unknown status NCT01807858 - The Effects of Synbiotics on Morbidity and Mortality in Preterm Infants N/A
Completed NCT01745510 - Enteral Administration of Docosahexaenoic Acid to Prevent Necrotizing Enterocolitis in Preterm Neonates Phase 1/Phase 2
Completed NCT01735578 - Splanchnic Tissue Oxygenation During Enteral Feedings in Anemic Premature Infants at Risk for Necrotizing Enterocolitis N/A